Silybin supplementation during HCV therapy with pegylated interferon-α plus ribavirin reduces depression and anxiety and increases work ability
OPEN BMC psychiatry | 16 Nov 2016
G Malaguarnera, G Bertino, G Chisari, M Motta, M Vecchio, M Vacante, F Caraci, C Greco, F Drago, G Nunnari and M Malaguarnera
Abstract
Hepatitis C virus infection and interferon treatment are often associated with anxiety, depressive symptoms and poor health-related quality of life. To evaluate the Silybin-vitamin E-phospholipids complex effect on work ability and whether health related factors (anxiety and depression) were associated with work ability in subjects with chronic hepatitis C treated with Pegylated-Interferon-α2b (Peg-IFN) and Ribavirin (RBV).
- Tweets*
- 1
- Facebook likes*
- 0
- Reddit*
- 0
- News coverage*
- 0
- Blogs*
- 0
- SC clicks
- 1
- Concepts
- Hepatocellular carcinoma, Hepatitis C virus, Hepatitis, Ribavirin, Interferon, Virus, Hepatitis B, Hepatitis C
- MeSH headings
- -
comments powered by Disqus
* Data courtesy of Altmetric.com